Skip to content
CROI 2023 Overall Evaluation
*
1.
How did you participate?
(Required.)
In-person
Virtually
2.
How have you participated in past CROIs? (Select all that apply.)
In person
Virtually
NA/this is my first CROI
3.
License(s) or degree(s) (Select all that apply.)
MD
PhD
MD/PhD
DO
MBBS
MBChB
PharmD
Other (please specify)
4.
In what country do you reside?
Afghanistan
Albania
Algeria
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia (Plurinational State of)
Bosnia and Herzegovina
Botswana
Brazil
British Virgin Island
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Cayman Islands
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo
Costa Rica
Côte D'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Democratic People's Republic of Korea
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Holy See
Honduras
Hungary
Iceland
India
Indonesia
Iran (Islamic Republic of)
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People’s Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia (Federated States of)
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of Korea
Republic of Moldova
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
State of Palestine
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
The former Yugoslav Republic of Macedonia
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela (Bolivarian Republic of)
Vietnam
Yemen
Zambia
Zimbabwe
5.
Please select your role at CROI 2023. (Select all that apply.)
Program Committee Member
External Reviewer
Invited Speaker/Moderator/Leader
Presenting Author
Collaborators
Scholarship Recipient
Participant
6.
Please describe your participation at CROI 2023. (Select all that apply.)
General attendee
Scholarship recipient
Plenary speaker
Oral abstract presenter
Coauthor on oral abstract
Oral abstract session moderator
Themed discussion presenter
Themed discussion session moderator
Poster presenter
Poster walk leader
Coauthor on poster
Symposium moderator
Symposium presenter
Workshop moderator
Workshop presenter
Member of the media
Program committee member
Other (please specify)
7.
What is your primary area of interest at CROI? (Pick one.)
Basic science
Clinical research
Epidemiology
Prevention
Public health
8.
Which virus were you most interested in at CROI 2023? (Pick one.)
HIV
SARS-CoV-2/COVID-19
Hepatitis viruses
Monkeypox
Other viruses
9.
Number of years you have been working in the HIV/AIDS field.
0
1-3
4-7
8-12
13-20
21-30
More than 30
10.
How many individuals with HIV are presently under your direct care?
1-4
5-10
11-15
16-50
51-100
101-300
301-500
More than 500
None/NA
11.
Please rate the Opening Session overall.
Excellent
Very good
Good
Fair
Poor
N/A
Value in fulfilling the overall learning objectives for the conference
Excellent
Very good
Good
Fair
Poor
N/A
Value to your clinical, research, or other responsibility
Excellent
Very good
Good
Fair
Poor
N/A
Format of the session
Excellent
Very good
Good
Fair
Poor
N/A
Overall freedom of commercial bias
Excellent
Very good
Good
Fair
Poor
N/A
Please comment:
12.
Please rate the Plenaries overall.
Excellent
Very good
Good
Fair
Poor
N/A
Value in fulfilling the overall learning objectives for the conference
Excellent
Very good
Good
Fair
Poor
N/A
Value to your clinical, research, or other responsibility
Excellent
Very good
Good
Fair
Poor
N/A
Format of the plenaries
Excellent
Very good
Good
Fair
Poor
N/A
Overall freedom of commercial bias
Excellent
Very good
Good
Fair
Poor
N/A
Please comment: